Back
Organogenesis Holdings Quote, Financials, Valuation and Earnings
Earn Your Weekly "Paycheck" with Chuck's Secret Income Strategy!
Act now for your path to extra income!
Buy
54
ORGO
Organogenesis Holdings
Last Price:
2.50
Seasonality Move:
6.45%
7 Day Trial
ALL ACCESS PASS
$
7
America's Final Republican President
Click here to see his 2024 election prediction.Organogenesis Holdings Price Quote
$2.50
+0.01 (+0.2%)
(Updated: May 4, 2024 at 6:31 AM ET)
Organogenesis Holdings Key Stats
Buy
54
Organogenesis Holdings (ORGO)
is a Buy
Day range:
$2.46 - $2.64
52-week range:
$1.96 - $4.71
Dividend yield:
0%
P/E ratio:
62.25
P/S ratio:
0.76
P/B ratio:
1.18%
Volume:
895K
Avg. volume:
1.1M
1-year change:
20.87%
Market cap:
$328.6M
Revenue:
$433.1M
EPS:
$0.04
How Much Does Organogenesis Holdings Make?
-
How Much Are Organogenesis Holdings's Sales Annually?
ORGO Revenues are $433.1M -
How Much Profit Does Organogenesis Holdings's Make A Year?
ORGO net income is $4.9M
Is Organogenesis Holdings Growing As A Company?
-
What Is Organogenesis Holdings's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.14% -
What Is Organogenesis Holdings's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Organogenesis Holdings Stock Price Performance
-
Did Organogenesis Holdings Stock Go Up Last Month?
Organogenesis Holdings share price went down by -10.11% last month -
Did ORGO's Share Price Rise Over The Last Year?
ORGO share price rose by 20.87% over the past 1 year
What Is Organogenesis Holdings 52-Week High & Low?
-
What Is Organogenesis Holdings’s 52-Week High Share Price?
Organogenesis Holdings has traded as high as $4.71 over the past 52 weeks -
What Is Organogenesis Holdings’s 52-Week Low Share Price?
Organogenesis Holdings has traded as low as $1.96 over the past 52 weeks
Organogenesis Holdings Price To Free Cash Flow
-
Is Organogenesis Holdings Stock Overvalued?
Organogenesis Holdings is trading at a price to free cash flow ratio of 50.36 -
Is Organogenesis Holdings Stock Undervalued?
Organogenesis Holdings EV to Free Cash Flow ratio is 44.40 -
What Is Organogenesis Holdings’s Price Earnings Growth Ratio?
ORGO PEG ratio is 0.00 -
Is Organogenesis Holdings Trading At A Premium To Earnings?
Organogenesis Holdings EV to EBIT ratio is 23.13
Is It Risky To Buy Organogenesis Holdings?
-
How Much Debt Does Organogenesis Holdings Have?
Total long term debt quarterly is $66.2M -
How Much Cash Does Organogenesis Holdings Have?
Cash and short term investments quarterly total is $103.8M -
What Is Organogenesis Holdings’s Book Value Per Share?
Book value per share is 2.12
Is Organogenesis Holdings Cash Flow Positive?
-
What Is ORGO Cash Flow From Operations?
Cash flow from operations (TTM) is $30.9M -
What Is Organogenesis Holdings’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$5.5M -
What Is Organogenesis Holdings’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$24.4M
Organogenesis Holdings Return On Invested Capital
-
Is Management Doing A Good Job?
ORGO return on invested capital is 1.46% -
What Is Organogenesis Holdings Return On Assets?
ROA measures how assets are converting to revenues and is 1.09% -
What Is ORGO Return On Equity?
ROE is a measure of profitability and is 1.82%
Organogenesis Holdings Earnings Date & Stock Price
-
What Is Organogenesis Holdings's Stock Price Today?
A single share of ORGO can be purchased today for 2.49 -
What Is Organogenesis Holdings’s Stock Symbol?
Organogenesis Holdings trades on the nasdaq under the ticker symbol: ORGO -
When Is Organogenesis Holdings’s Next Earnings Date?
The next quarterly earnings date for Organogenesis Holdings is scheduled on May 9, 2024 -
When Is ORGO's next ex-dividend date?
Organogenesis Holdings's next ex-dividend date is May 5, 2024 -
How To Buy Organogenesis Holdings Stock?
You can buy Organogenesis Holdings shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Organogenesis Holdings Competitors
-
Who Are Organogenesis Holdings's Competitors?
Below is a list of companies who compete with Organogenesis Holdings or are related in some way:
Organogenesis Holdings Dividend Yield
Data Unavailable
Organogenesis Holdings Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -27% |
| Revenue: | -13.73% | -8.62% |
Analyst Recommendations
| Buy Recommendations: | 2 |
|---|---|
| Hold Recommendations: | 1 |
| Sell Recommendations: | 0 |
| Price Target: | 4.83 |
| Upside from Last Price: | 94.11% |